160 related articles for article (PubMed ID: 29507069)
1. Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses.
Vigil A; Estélles A; Kauvar LM; Johnson SK; Tripp RA; Wittekind M
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29507069
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
[TBL] [Abstract][Full Text] [Related]
3. Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies.
Vigil A; Frias-Staheli N; Carabeo T; Wittekind M
J Virol; 2020 Oct; 94(22):. PubMed ID: 32847855
[TBL] [Abstract][Full Text] [Related]
4. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
5. Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective.
Madsen A; Dai YN; McMahon M; Schmitz AJ; Turner JS; Tan J; Lei T; Alsoussi WB; Strohmeier S; Amor M; Mohammed BM; Mudd PA; Simon V; Cox RJ; Fremont DH; Krammer F; Ellebedy AH
Immunity; 2020 Oct; 53(4):852-863.e7. PubMed ID: 32976769
[TBL] [Abstract][Full Text] [Related]
6. A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses.
Shen C; Chen J; Li R; Zhang M; Wang G; Stegalkina S; Zhang L; Chen J; Cao J; Bi X; Anderson SF; Alefantis T; Zhang M; Cai X; Yang K; Zheng Q; Fang M; Yu H; Luo W; Zheng Z; Yuan Q; Zhang J; Wai-Kuo Shih J; Kleanthous H; Chen H; Chen Y; Xia N
Sci Transl Med; 2017 Oct; 9(412):. PubMed ID: 29046433
[TBL] [Abstract][Full Text] [Related]
7. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
8. [Monoclonal antibodies to hemagglutinin of influenza b viruses victoria evolutionary lineage.].
Sorokin EV; Tsareva TR; Zheltukhina AI
Vopr Virusol; 2018; 63(6):275-280. PubMed ID: 30641023
[TBL] [Abstract][Full Text] [Related]
9. Cross-lineage protection by human antibodies binding the influenza B hemagglutinin.
Liu Y; Tan HX; Koutsakos M; Jegaskanda S; Esterbauer R; Tilmanis D; Aban M; Kedzierska K; Hurt AC; Kent SJ; Wheatley AK
Nat Commun; 2019 Jan; 10(1):324. PubMed ID: 30659197
[TBL] [Abstract][Full Text] [Related]
10. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts.
Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H
Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815
[TBL] [Abstract][Full Text] [Related]
11. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P
PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection and identification of two lineages of influenza B strains with monoclonal antibodies.
Nakagawa N; Maeda A; Kase T; Kubota R; Okuno Y
J Virol Methods; 1999 Apr; 79(1):113-20. PubMed ID: 10328540
[TBL] [Abstract][Full Text] [Related]
13. Production of highly and broad-range specific monoclonal antibodies against hemagglutinin of H5-subtype avian influenza viruses and their differentiation by mass spectrometry.
Sączyńska V; Bierczyńska-Krzysik A; Cecuda-Adamczewska V; Baran P; Porębska A; Florys K; Zieliński M; Płucienniczak G
Virol J; 2018 Jan; 15(1):13. PubMed ID: 29334981
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice.
Liu Y; Li H; Xue Y; Zhao S; Li C; Qu L; Zhang Y; Liu M
Viruses; 2017 Aug; 9(8):. PubMed ID: 28786930
[TBL] [Abstract][Full Text] [Related]
15. Domestic pigs are susceptible to infection with influenza B viruses.
Ran Z; Shen H; Lang Y; Kolb EA; Turan N; Zhu L; Ma J; Bawa B; Liu Q; Liu H; Quast M; Sexton G; Krammer F; Hause BM; Christopher-Hennings J; Nelson EA; Richt J; Li F; Ma W
J Virol; 2015 May; 89(9):4818-26. PubMed ID: 25673727
[TBL] [Abstract][Full Text] [Related]
16. [Epitope analysis of the hemagglutinin molecule of the Victoria lineage influenza B viruses].
Sorokin EV; Tsareva TR; Sominina AA; Pisareva MM; Komissarov AV; Kosheleva AA; Grudinin MP
Vopr Virusol; 2014; 59(6):27-31. PubMed ID: 25929033
[TBL] [Abstract][Full Text] [Related]
17. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
Simmons CP; Bernasconi NL; Suguitan AL; Mills K; Ward JM; Chau NV; Hien TT; Sallusto F; Ha do Q; Farrar J; de Jong MD; Lanzavecchia A; Subbarao K
PLoS Med; 2007 May; 4(5):e178. PubMed ID: 17535101
[TBL] [Abstract][Full Text] [Related]
19. A Single Amino Acid in the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses.
Bae JY; Lee I; Kim JI; Park S; Yoo K; Park M; Kim G; Park MS; Lee JY; Kang C; Kim K; Park MS
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643248
[TBL] [Abstract][Full Text] [Related]
20. Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface.
Wolters RM; Ferguson JA; Nuñez IA; Chen EE; Sornberger T; Myers L; Oeverdieck S; Raghavan SSR; Kona C; Handal LS; Esilu TE; Davidson E; Doranz BJ; Engdahl TB; Kose N; Williamson LE; Creech CB; Gibson-Corley KN; Ward AB; Crowe JE
Immunity; 2024 Jun; 57(6):1413-1427.e9. PubMed ID: 38823390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
